Schedule 13D ownership disclosure
Talis Biomedical Corp
Security class unavailable · CUSIP: 87424L108
Event date: 2021-02-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 37,432,057
- Percent of class
- 67.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-029310
- Form type
- SC 13D
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- Feb 26, 2021
- Reporting period
- Feb 17, 2021
- Description
- Schedule 13D beneficial ownership